US 12,247,200 B2
Compositions and methods for generating massively parallel nucleic acid sequencing libraries
Kevin D. Allen, Austin, TX (US); and Kerry Gunning, Austin, TX (US)
Assigned to BIOO Scientific Corporation, Austin, TX (US)
Filed by BIOO Scientific Corporation, Austin, TX (US)
Filed on Feb. 22, 2021, as Appl. No. 17/181,947.
Claims priority of provisional application 63/018,712, filed on May 1, 2020.
Claims priority of provisional application 62/979,697, filed on Feb. 21, 2020.
Prior Publication US 2021/0261952 A1, Aug. 26, 2021
Int. Cl. C12N 15/10 (2006.01); C12Q 1/6876 (2018.01)
CPC C12N 15/1093 (2013.01) [C12Q 1/6876 (2013.01)] 8 Claims
 
1. An oligonucleotide primer, comprising, from 5′ to 3′, a 5′ primer tag sequence (PTS) covalently bonded to a 5′ residue of a homopolymer-hybridizing region, wherein the PTS consists of a linker and/or one or more nucleic acid sequences useful in nucleic acid sequence manipulation selected from: a sequencing site, a PCR site, and a hybridization site; the homopolymer-hybridizing region, and an anchor region comprising 5′-(λ)nNm-3′, wherein the homopolymer-hybridizing region hybridizes to a complementary homopolymer tract of a target nucleic acid, wherein the complementary homopolymer tract comprises a contiguous sequence of complementary elements, wherein the homopolymer-hybridizing region, and the anchor region together have a sequence selected from the group consisting of: SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, and SEQ ID NO: 15, and wherein λ is any nucleotide or nucleotide analog with the proviso that k is not a nucleotide or nucleotide analog complementary to a complementary element of the complementary homopolymer tract, and wherein N is any nucleotide or nucleotide analog.